-
FDA Approves Pfizer Lung-Cancer Drug
28.08.2011The U.S. Food and Drug Administration approved a Pfizer Inc. drug that shrinks tumors in lung-cancer patients with a rare genetic abnormality, the latest molecularly targeted therapy to win a rapid approval from the agency.
прочети -
Study: Cancer trial participation less than 1%
28.08.2011As conventional wisdom dictates, in order to solve a problem, one must first define it. Low enrollment in cancer drug trials has been a problem for developers, but a new study shows just how dire the situation really is. Less than 1% of cancer patients in one survey enrolled in a clinical trial, according to the study.
прочети -
Vitamin A pills could save thousands of children
28.08.2011Giving vitamin A supplements to children under the age of five in developing countries could save 600,000 lives a year, researchers claim.
прочети -
Psoriasis linked to stroke risk
28.08.2011People with psoriasis have nearly three times the normal risk of stroke and abnormal heart rhythm, according to scientists in Denmark.
прочети -
Scientists find weakness in deadly Ebola virus
28.08.2011Reuters - A protein that helps transport cholesterol inside cells may be a key to developing drugs to treat Ebola, a rare but lethal virus for which there are no known treatments, U.S. researchers said.
прочети -
Bio-Images-CPS Research partnership offers streamlined formulation route
28.08.2011A strategic partnership between two research organisations based in Glasgow, Scotland will combine formulation expertise with clinical trial capabilities to streamline the development and passage to market of new, enhanced drug formats.
прочети -
NICE final "no" for BM-S' Orencia in RA
28.08.2011The National Institute for Health and Clinical Excellence (NICE) has issued final guidance rejecting the use of Bristol-Myers Squibb's Orencia (abatacept) as a second-line treatment for rheumatoid arthritis (RA).
прочети -
Boehringer/Lilly's diabetes drug gets Europe OK
28.08.2011Boehringer Ingelheim and partner Eli Lilly are celebrating the news that regulators in Europe have given the green light to their once-daily type 2 diabetes pill Trajenta.
прочети -
Хвърчащ лист смени здравната карта за ЕС
28.08.2011Хвърчащ лист смени здравната карта за пътуване в чужбина, алармираха пациентските организации.
прочети -
Защо движението предпазва от болести
27.08.2011Не само пълните хора се нуждаят от повече движения. Нещо повече - от физическата активност зависи не само доколко стройна е фигурата, но и настроението, съобразителността и т.н. Ето няколко доказателства за това
прочети